Ondansetron Injection
Product Images NDC 71872-7140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71872-7140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (07140)

Pdp (07140)
This is a description of Ondansetron Injection, a medication to be administered through IV or IM injection. It is sold in a 2 mL vial with a concentration of 2 mg/mL. Each 1 mL of aqueous solution contains 2 mg of ondansetron hydrochloride. The medication should be stored at 25C (68°-77°F) and protected from light. The manufacturer of the medication is Wostard Estontoun located in NJ, USA. Dosage and administration instructions can be found in the package insert.*
FDA Label Image

Structural Formula (Ondansetron Injection Usp 1)

FDA Label Image

Ondansetron Injection, Usp 4 mg/2 mL (2 mg/ml) 2 mL Single Dose Vial (Ondansetron Injection Usp 2)

Ondansetron Injection, Usp 4 mg/2 mL (2 mg/ml) 2 mL Single Dose Vial (Ondansetron Injection Usp 2)
NDC 0641-6078-01 is a drug product with the brand name Ondansetron. It is an injection medication and is USP approved. The manufacturer of this drug is Westward Pharmaceuticals. The rest of the text appears to be non-readable characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.